Press Releases Keyword Search Year None2022202120202019201820172016201520142013 Feb 08, 2022 Seres Therapeutics Appoints Paula Cloghessy as Executive Vice President, Chief People Officer Jan 24, 2022 Seres Therapeutics to Host Virtual Investor Event Highlighting Opportunities for Microbiome Therapeutics in Infection Protection on January 31, 2022 Jan 19, 2022 New England Journal of Medicine Publishes Data from ECOSPOR III Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection Jan 04, 2022 Seres Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Feb 08, 2022 Seres Therapeutics Appoints Paula Cloghessy as Executive Vice President, Chief People Officer
Jan 24, 2022 Seres Therapeutics to Host Virtual Investor Event Highlighting Opportunities for Microbiome Therapeutics in Infection Protection on January 31, 2022
Jan 19, 2022 New England Journal of Medicine Publishes Data from ECOSPOR III Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection
